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Infection by virulent Mycobacterium avium caused progressive severe lymphopenia in C57BL/6 mice due to
increased apoptosis rates. T-cell depletion did not occur in gamma interferon (IFN-)-deficient mice which
showed increased T-cell numbers and proliferation; in contrast, deficiency in nitric oxide synthase 2 did not
prevent T-cell loss. Although T-cell loss was IFN- dependent, expression of the IFN- receptor on T cells was
not required for depletion. Similarly, while T-cell loss was optimal if the T cells expressed IFN-, CD8 T-cell
depletion could occur in the absence of T-cell-derived IFN-. Depletion did not require that the T cells be
specific for mycobacterial antigen and was not affected by deficiencies in the tumor necrosis factor receptors
p55 or p75, the Fas receptor (CD95), or the respiratory burst enzymes or by forced expression of bcl-2 in
hematopoietic cells.
Upon encountering antigen, specific T cells proliferate and
differentiate into effectors of varied types according to distinct
signals in their environment. This expansion is usually followed
by a contraction phase where T cells disappear as they undergo
apoptosis and are thus eliminated, together with the removal
of the antigenic challenge (1). In certain infectious diseases
where the microbe resists killing by the immune system, this
sequence of events may not always be present as antigenic
stimulation persists for prolonged periods of time. Examples of
such infections are found following invasion of the host by
different mycobacterial genera, schistosoma, and human im-
munodeficiency virus. In those infections, microbial persis-
tence is accompanied by immunopathological findings, includ-
ing the development of necrosis, fibrosis, and lymphopenia.
T-cell loss has been observed during Mycobacterium avium
infections. Using a disseminated model of M. avium infection
induced by the intravenous inoculation of high numbers of
viable mycobacteria, we reported that a highly virulent strain
(ATCC 25291 with a smooth-transparent SmT morphotype)
induced extensive T-cell depletion in the spleens of infected
mice (9, 10). In contrast, a less virulent strain (M. avium 2447)
did not (9). In a different model of infection initiated by ex-
posure to an intratracheal infection, Cheers and colleagues
dissected the development of severe anergy associated with
pronounced T-cell loss at late stages of M. avium infection (13,
14, 24). In the latter studies, such T-cell loss was observed at
different sites of infection and was explained by the increase in
apoptosis of T cells in infected animals (14). More recently, it
was shown to be mediated by CD95 in CD4 T cells and
prevented by Bcl-2 in CD8 T cells (38). T-cell loss was also
described during Mycobacterium bovis BCG infection by Dal-
ton and coworkers (5). In their study, they were able to incrim-
inate IFN- and nitric oxide (NO) as the culprits of such phe-
nomenon. However, the role of IFN- and NO has not been
analyzed in an in vivo model of T-cell loss, namely, during
M. avium infections.
The mechanisms of T-cell depletion may vary according to
each specific case. T cells may die by “neglect” due to lack of
costimulation namely by deficient production of interleukin-2
(IL-2) and other cytokines or may die when certain death
receptors are triggered (18). Among the latter one can find
tumor necrosis factor (TNF) receptor superfamily (TNFRSF)
members such as the TNF receptors (TNFR), TNF-related
apoptosis-inducing ligand receptors, CD95/Fas, and death re-
ceptor 3 (23). Cytokines such as IL-10, IL-6, and transforming
growth factor 1 (TGF-1) have been found to inhibit T-cell
death (2, 12, 34) whereas IFN- has been known for its death
promoting activity (22). Free radicals may also lead to T-cell
apoptosis (5, 19).
Here, we attempted to determine the mechanism by which
T-cell loss occurred during infection with the virulent 25291
strain of M. avium. Our principal tool was a panel of gene-
deficient animals wherein we determined the relationship be-
tween T-cell numbers, IFN- production, and susceptibility to
infection by M. avium. Since IFN- has been suggested to be
responsible for T-cell death in mycobacterial infections (5), we
studied mice deficient in IFN-, mice deficient in a cytokine
that regulates its production (IL-12) and mice deficient in the
generation of reactive oxygen and nitrogen species, also
known for their apoptosis-inducing activity (5, 19), given that
IFN- primes phagocytes for the enhanced production of these
molecules. Similarly, the known involvement of TNF- in the
apoptosis of T cells (23, 37) implicated this cytokine in T-cell
depletion and we therefore studied mice deficient in this cyto-
kine as well as mice deficient in the expression of its receptors.
In order to identify specific apoptotic mechanisms in the T-cell
depletion, we analyzed mice lacking the expression of the
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death receptor CD95/Fas (23, 37) and mice overexpressing the
apoptosis-inhibiting protein BCL-2 (16). Our data incriminate
IFN- as a mediator of the T-cell depletion.
MATERIALS AND METHODS
Mice. A complete listing of the mutant mice used in this study with a brief
description of their phenotypes, justifying their use here, is shown in Table 1.
Female C57BL/6J, B6.TNFRSF1a/ (p55/), B6.TNFRSF1b/ (p75/),
B6.MRL.lpr, B6.IFN-/, B6.IFN--R/, B6.IL12p40/, and Rag-2/ mice
were purchased from the Jackson Laboratories (Bar Harbor, ME). Breeder mice
for strain B6.TNF/ were purchased from Bantin and Kingman Universal
(North Humberside, United Kingdom). Progeny was obtained in our facilities.
NOS2-deficient mice were bred in our facilities from a breeding pair kindly
provided by J. D. MacMicking and C. Nathan (Cornell University, New York,
NY) and J. Mudgett (Merck Research Laboratories, Rahway, NJ). NOS2-defi-
cient mice in a C57BL/6 background (B6.NOS2/) were obtained by backcross-
ing the original strain into a C57BL/6 background for seven generations. Trans-
genic mice overexpressing human BCL2 in the hematopoietic cell lineage
(C57BL/6/bcl2) were kindly supplied by J. Adams (Walter and Eliza Hall Insti-
tute of Medical Research, Melbourne, Australia [25]). NADPH oxidase-deficient
B6.p47phox/ mice were a gift from S. Holland (National Institute of Allergy
and Infectious Diseases, National Institutes of Health, Bethesda, MD). C57BL/6
mice engineered to express green fluorescent protein (GFP) (B6.GFP) (36) were
crossed, at the Trudeau Institute, to transgenic mice that express the V3/V11
T-cell receptor (TCR) that recognizes a pigeon cytochrome c peptide in the
context of I-Ek (17). Mice were kept in high-efficiency particulate air filter-
bearing cages and fed autoclaved chow (Harlan) and water. Female mice were
used at 6 to 9 weeks of age.
Bacteria.M. avium strain 25291, exhibiting a smooth-transparent morphotype,
was obtained from the American Type Culture Collection (Manassas, VA).
Mycobacteria were grown in Middlebrook 7H9 medium (Difco, Detroit, MI)
containing 0.04% Tween 80 (Sigma, St. Louis, MO) at 37°C until the mid-log
phase of growth. Bacteria were harvested by centrifugation and resuspended in
a small volume of saline containing 0.04% Tween 80. The bacterial suspension
was briefly sonicated with a Branson sonifier (Danbury, CT) to disrupt bacterial
clumps, diluted, and stored in aliquots at 70°C until used. Before inoculation,
bacterial aliquots were thawed at 37°C and diluted in saline to the desired
concentration.
In vivo infection. Female mice aged 6 to 9 weeks were infected intravenously
with 106 CFU of M. avium strain 25291 through a lateral tail vein. Infected mice
were sacrificed at different time points of infection, and the livers, spleens, and
lungs were aseptically collected and homogenized in a 0.04% Tween 80 solution
in distilled water. The number of CFU of M. avium in the organs of the infected
mice was determined by serial dilution and plating of the tissue homogenates
into Middlebrook 7H10 agar medium (Difco, Sparks, MD) supplemented with
oleic acid-albumin-dextrose-catalase. The number of bacterial colonies was
counted after culture for 2 weeks at 37°C. Statistical comparisons of the myco-
bacterial loads between deficient and control mice were performed using the
Student’s t test.
Cell preparation. A single-cell suspension was prepared from the spleen by
passing the organ through a 70-m nylon cell strainer and lysing the red blood
cells by using Gey’s solution (29). Lung cell suspensions were prepared by
perfusing cold saline containing heparin through the heart. Once lungs appeared
white, they were removed and sectioned in ice-cold medium using sterile razor
blades. Dissected lung tissue was then incubated in Collagenase IX (0.7 mg/ml;
Sigma) and DNase (30 g/ml; Sigma) at 37°C for 30 min (29). Digested lung
tissue was gently disrupted by passage through a 70-m nylon cell strainer, and
the resultant single-cell suspension was treated with Gey’s solution to remove any
residual red blood cells, washed twice, and counted. Cells prepared in this way
were used for flow cytometric analyses.
Detection of IFN-. Single-cell suspensions from the spleens of each of the
infected mice were prepared by teasing portions of the spleen with forceps in
Dulbecco’s modified Eagle tissue culture medium (DMEM; Life Technologies,
Paisley, United Kingdom) supplemented with 10% fetal calf serum (FCS; Life
Technologies). Erythrocytes were lysed by incubation of the cell suspensions with
hemolytic buffer (155 mM NH4Cl, 10 mM KHCO3, pH 7.2) for 5 min at room
temperature. The cell suspensions were then thoroughly washed with Hanks’
balanced salt solution (HBSS; Life Technologies) and resuspended in DMEM
with 10% FCS. Cells were cultivated at a density of 2  105 cells/well in a
U-bottom 96-well microtiter plate. Cells were incubated in triplicate in DMEM
with 10% FCS with no further stimulus or in the presence of mycobacterial
envelope proteins (4 g/ml). Supernatants from the cultures were collected after
96 h of culture, and the IFN- produced was quantified by a two-site sandwich
enzyme-linked immunosorbent assay (ELISA) method using anti-IFN--specific
affinity-purified monoclonal antibodies (R4-6A2 as capture and biotinylated
AN-18 as detecting antibody) and a standard curve generated with known
amounts of recombinant murine IFN- (Genzyme, Cambridge, CA). The sensi-
tivity of the assay was 30 pg/ml. Serum from infected mice was obtained after
allowing the blood to clot, and IFN- titers were determined as described
previously. Mycobacterial envelope proteins were prepared from M. avium strain
25291 grown in Sauton medium as described elsewhere (26).
Flow cytometry. For the immunofluorescence staining, 106 cells were incu-
bated in a 96-well microtiter plate with fluorescein isothiocyanate (FITC)-con-
jugated anti-CD4 antibody (dilution, 1:100) and phycoerythrin (PE)-conjugated
anti-CD8 antibody (dilution, 1:100) or FITC-conjugated anti-CD19 antibody
(dilution, 1:100) and PE-conjugated anti-MAC-1 antibody (dilution, 1:100) in
phosphate-buffered saline (PBS) containing 3% FCS. All antibodies were from
BD Pharmingen (San Diego, CA). The cells were washed twice with PBS con-
taining 3% FCS, and propidium iodide (Sigma, St. Louis, MO) was added to the
cells at a final concentration of 1 g/ml to allow the exclusion of dead cells. The
analysis of the cell populations was based on the acquisition of 10,000 events in
a Becton Dickinson FACSort instrument equipped with CellQuest software.
Alternatively, single-cell suspensions of cells were stained with labeled antibodies
specific for CD4 (allophyocyanin-labeled clone GK1.5), CD3 (peridinin chloro-
phyll protein [PerCP]-labeled clone 145-2C11), and CD44 (FITC-labeled clone
IM7). Cells were then fixed and permeabilized, and the presence of intranuclear
BrdU was determined using a (PE)-labeled antibody (BrdU flow kit; Becton
Dickinson). Cells were analyzed using CellQuest on a Becton Dickinson FAC-
SCalibur dual-laser flow cytometer with excitation at 488 nM and 633 nM.
Lymphocytes were gated based on their forward and side-scatter characteristics
and then on CD4 and CD3, and the numbers of such lymphocytes per organ were
determined. CD4-positive lymphocytes were then analyzed for their expression
of BrdU, and this frequency was applied to the total number of CD4 T cells per
organ to determine the number of recently proliferated cells per organ. For the
analysis of apoptotic cells, a total of 5  105 splenic cells were incubated in a
TABLE 1. List of the strains used in this work to assess the role of individual molecules in the fate of infection and
of T cells and brief descriptions of their phenotypes
Strain Genetic defecta Phenotype and rationale for use in this work (references)
B6.TNFRSF1a/ TM of tnfrsf1a Does not express type 1 (p55) TNF receptors involved in apoptosis, namely, of T cells (23)
B6.TNFRSF1b/ TM of tnfrsf1b Does not express type 2 (p75) TNF receptors
B6.TNF/ TM of tnfsf2 Lacks production of TNF-, which may induce apoptosis in many cell types, namely, of T cells (23, 37)
B6.MRL.lpr SP of tnfrsf6 Does not express CD95/Fas, which is involved in apoptosis, namely, of T cells (23, 37)
B6.IFN/ TM of ifng Lacks production of IFN-, which activates macrophages and can lead to apoptosis of lymphocytes (5)
B6.IL12p40/ TM of il12b Lacks production of IL12p40, which activates T cells for IFN- secretion
B6.NOS2/ TM of nos2 Lacks the inducible nitric oxide synthase, and macrophages do not produce NO involved in apoptosis,
namely, of T cells (5)
B6.p47phox/ TM of ncf1 Lacks the cytosolic 47-kDa component of phagocytes’ NADPH oxidase (p47phox) and have deficient
respiratory burst and consequently reduced apoptosis mediated by oxygen-free radicals (19)
C57B1/6/bcl2 TG of human bcl-2 Expression of human BCL-2 under the vav promoter leads to overexpression of BCL-2 in hematopoietic
cells, causing inhibition of the mitochondrial pathways of apoptosis (16, 25)
a TM, targeted mutation; SP, spontaneous mutant; TG, expressing a transgene leading to the expression of a new gene product.
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96-well microtiter plate with either PE-conjugated anti-CD4 antibody or PE-
conjugated anti-CD8 antibody (Pharmingen) at a dilution of 1:100 in PBS con-
taining 3% FCS for 30 min. The cells were washed twice with PBS–3% FCS and
a third time with binding buffer (10 mM HEPES buffer containing 0.14 mM NaCl
and 2.5 mM CaCl2, pH 7.4) and incubated in 100 l binding buffer containing 5
l of FITC-conjugated annexin V (Pharmingen) and 4 l of 7-AAD (Pharmin-
gen) for 15 min at room temperature in the dark. The stained cell suspensions
were then diluted in binding buffer to a final volume of 0.5 ml and immediately
analyzed.
BrdU incorporation assay. C57BL/6 and B6.IFN-/ were intravenously
infected with 105 M. avium 25291. At specific times postinfection, mice were
given 1 g of the nucleotide analog bromodeoxyuridine (BrdU) via the intra-
peritoneal route. Twenty-four hours post-BrdU delivery, mice were euthanized
and the lungs and spleens harvested.
Chimerization of Rag-deficient mice. Spleen cells were isolated from control
C57BL/6 mice or from mutant mice and incubated for 2 h in a nylon wool column
(1.2 g per 10-ml column) in DMEM containing 2% FCS. Nonadherent cells were
recovered by gently washing the columns with 20 ml of warmed culture medium.
This T-cell-enriched population of spleen cells (routinely, a purification of 80%
CD3-positive cells was obtained) was washed and intravenously transfused into
Rag1/ mice (one spleen cell equivalent per mouse, around 20  106 cells).
Recipient mice were allowed to repopulate the lymphoid organs for 3 weeks (30)
before we infected them with M. avium.
Adoptive transfer of GFP-expressing T cells. Naı¨ve CD4 T cells were isolated
from mice expressing a pigeon cytochrome c peptide-specific TCR transgene and
a GFP transgene and cultured with peptide antigen and cytokines to generate
Th1 effector CD4 T cells as previously described (17). Briefly, CD4 T cells were
cultured with the DCEK-ICAM fibroblast cell line (I-Ek, B7.1, B7.2, and
ICAM-1) at a 2:1 ratio (CD4:antigen-presenting cell) in the presence of the
pigeon cytochrome c peptide fragment from amino acids 88 through 104 as the
antigen at a dose of 5 M and with exogenously added IL-2 (80 U/ml), IL-12 (2
ng/ml), and anti-IL-4 (10 g/ml). Four-day in vitro-derived CD4 T-cell effectors
were then transferred into either C57BL/6 or B6.IFN-/ mice infected 30 days
previously with 105 M. avium 25291 or uninfected C57BL/6 mice or B6.IFN-/
mice (107 cells per mouse). Four days following transfer, the host mice were
euthanized and single-cell suspensions of the lung and spleen were prepared and
analyzed by flow cytometry. Cells were gated on the expression of the GFP and
then analyzed for the expression of CD4 and CD44 or for expression of the
annexin-V ligand and ability to exclude 7-AAD
Statistical analysis. Data were compared by using Student’s t test for paired
data and the analysis of variance test.
RESULTS
T-cell loss during infection of C57BL/6 mice with M. avium
25291, a highly virulent strain. When C57BL/6 mice are intra-
venously infected with high doses (106 CFU) of the virulent
M. avium strain ATCC 25291, there is a progressive uncon-
trolled infection despite the emergence of an immune response
characterized by prominent production of IFN- and extensive
macrophage activation (9). Concomitant with this uncontrolled
bacterial growth, progressive loss of T and B lymphocytes and
accumulation of macrophages can be detected in the spleen
(Fig. 1A). That the progressive loss of T lymphocytes may be
mediated by apoptosis was indicated by an increased frequency
of these cells that were positive for the surface expression of
phosphatidylserine, as determined by annexin V staining (Fig.
1B). The number of annexin V-positive CD4 cells was par-
ticularly high and peaked at day 30. From day 30 onwards, the
absolute number of apoptotic T cells dropped as a function of
the reduced number of lymphocytes within the spleen; how-
ever, the frequency of annexin V-positive cells within the T-cell
population remained above normal values (numbers beside
each point in Fig. 1B) until day 60 of infection, becoming sim-
ilar to control values at day 90, when very few viable cells re-
mained.
FIG. 1. Cellular composition in the spleens of C57BL/6 mice infected with 106 CFU of M. avium 25291. (A) Total number of CD19 (open
circles), Mac1 (diamonds), CD4 (closed squares), CD8 (open squares), and DX5 (closed circles) cells; (B) total number of annexin V7-
AAD cells gated on CD4 (closed squares) or CD8 (open squares) cells. The values indicated near each symbol indicate the range of per-
centages of annexin V 7-AAD cells among each population.
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Role of IFN- production in T-cell survival. Dalton et al. (5)
have shown that during BCG infection, IFN- leads to the
contraction of the T-cell response through the induction of
apoptosis of T cells and that such a phenomenon is mediated
by nitric oxide. To determine whether and how IFN-mediates
T-cell depletion in our model, we compared the T-cell re-
sponse in M. avium-infected B6 and B6.IFN-/ mice. In a
first analysis, we measured the ability of T cells to incorporate
BrdU as a measure of T-cell proliferation. As shown in Fig. 2A
and B, IFN--deficient mice showed increased accumulation of
recently proliferated T cells in response to the infection com-
pared to control C57BL/6 mice. This accumulation was seen in
both the spleen and the lung. The increased proliferation was
evident as an increase in the total number of BrdU-positive,
activated (CD44) T cells (not statistically significant) as well
as an increase in their frequency (statistically significant at day
25 of infection). It also appeared that activated effector CD4
T cells, defined by reduced expression of the CD62L selectin,
were more able to accumulate in the absence of IFN- (Fig.
2C).
IFN--deficient mice were as susceptible to bacterial growth
as control mice but failed to show the same profile of T-cell
depletion seen in the control mice. Specifically, the IFN--
deficient mice exhibited a pronounced expansion of T cells,
followed by an eventual contraction in the late stages of infec-
tion (Fig. 3A). Even though this contraction occurred, unlike
the control animals, where profound depletion was seen, T-cell
numbers never declined below the levels found in uninfected
animals. Similar data were obtained with IL-12p40/ mice
(Fig. 3A), which had severely impaired IFN- responses (no
cytokine was detectable in their serum or culture superna-
tants). In contrast, IFN- responses in NOS2/ mice were
enhanced compared to wild-type mice both in the serum (7.9-
fold at day 30; P 0.05) and upon in vitro stimulation (4.6-fold
at day 30 and 2.4-fold at day 60; P  0.05) and T-cell loss was
undistinguishable from that in control mice (Fig. 3A). Again,
in contrast to any other mouse investigated, the NOS2/ mice
were able to control mycobacterial proliferation and main-
tained a prolonged bacteriostasis lasting up to 4 months of
infection (Fig. 3A and data not shown), confirming previous
work from our group (15).
To determine whether the cellular source of IFN- was
important for the depletion of T cells to occur, we prepared
chimerized Rag-deficient mice harboring T cells from either
C57BL/6 or B6.IFN-/ mice. When these chimeric mice
were infected, T-cell depletion was significantly more extensive
in the B6 chimeras but still occurred in the B6.IFN-/ chi-
meras (Fig. 3B), although in the latter case, differences were
statistically significant for only CD8 T cells. To assess
whether IFN- acted directly on T cells to induce apoptosis
or through the action of other cell types, we chimerized
Rag/ mice with T cells lacking the IFN- receptor (i.e., from
B6.IFN--R/ mice). As shown in Fig. 3C, IFN--R-deficient
T cells were depleted to a level equivalent to that of IFN--
responsive T cells.
The observation that the majority of T cells (and B cells) are
FIG. 2. IFN- restricts T-cell proliferation during infection. C57BL/6 (closed symbols and columns) and B6.IFN-/ (open symbols and
columns) mice were intravenously infected with 105 M. avium. At specific times postinfection, mice were euthanized and lungs and spleens
harvested. Twenty-four hours prior to harvest, mice had been treated with 1 g of BrdU intraperitoneally. Tissues were processed for flow
cytometric analysis and BrdU labeling. Number (A) and frequency (B) of recently proliferated (BrdU) activated (CD44) CD4 T cells were
studied in the spleen and lung. The frequency of activated (CD62Llow) CD4 T cells was also studied in the spleen (C). Data points show means
of values derived from four individual mice at all time points (*, P  0.05).
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lost suggests that depletion of these cells is indiscriminate. To
confirm this was the case, we transferred CD4 TCR effector
cells specific for a non-M. avium antigen and which express
GFP as a detectable tracer either into M. avium-infected
C57BL/6 or B6.IFN-/ mice or into uninfected controls and
evaluated the survival of the transferred cells in the recipient
host. As shown in Fig. 4A, the transferred cells were less able
to persist in the spleens of infected mice than were those in the
spleens of noninfected hosts. This enhanced loss correlated
well with increased levels of apoptosis among the T cells (Fig.
4B). Furthermore, the induction of apoptosis among the trans-
ferred cells was more extensive when the cells were adminis-
tered to C57BL/6 mice than when they were given to IFN--
deficient animals (Fig. 4C), when evaluated in the spleens of
recipient mice.
IFN- appears from this data to be an indirect inducer of
T-cell loss during M. avium infection; however, nitric oxide
does not appear to be the responsible effector molecule. To
FIG. 3. Role of IFN- in infection-induced T-cell depletion. (A) Growth of M. avium ATCC 25291 in the spleen; number of splenic T cells in
C57BL/6 (closed squares), B6.IFN-/ (open squares), B6.IL12p40/ (triangles), and B6.NOS2/ (circles) mice; and IFN- concentrations in
the serum and culture supernatants of B6 (closed columns) and B6.NOS2/ (open columns) mice. No IFN- was detectable in the samples from
the B6.IFN-/ or B6.IL12p40/ mice. Results were confirmed in an independent experiment. (B) T-lymphocyte depletion in Rag/ mice that
received T-cell-enriched spleen cells from either C57BL/6 (Rag/B6) or B6.IFN-/ (Rag/GKO) mice 3 weeks before they were intravenously
infected with 106 CFU of M. avium 25291. Spleen cell populations were evaluated at 90 days of infection. Data represent the means of five mice
per group in one experiment. Statistically significant differences between infected and noninfected mice are labeled ** (P  0.01), whereas
differences between infected B6 chimeras (Rag/B6) and B6.IFN-/ chimeras (Rag/GKO) are labeled * (P  0.05). (C) T-lymphocyte depletion
in Rag/ mice that received T-cell-enriched spleen cells from either C57BL/6 (Rag/B6) or B6.IFN--R/ (Rag/GRKO) mice 3 weeks before they
were intravenously infected with 106 CFU of M. avium 25291. Spleen cell populations were evaluated at 90 days of infection. Data represent the
means of five mice per group in one experiment, and statistically significant differences between infected and noninfected mice are labeled ** (P
0.01). ND, not done.
FIG. 4. T cells are lost nonspecifically during infection. Splenocytes from uninfected B6.GFP mice were harvested and treated ex vivo to
generate effector cells. These pigeon cytochrome c-specific GFP effector cells were then transferred into non-GFP mice either that were uninfected
(open bars) or which had been infected 30 days previously (black bars). On day 4 posttransfer, recipient mice were euthanized and the number
of transferred GFP cells remaining in the spleen and lung was determined by flow cytometry (A) (*, P  0.002; **, P 	 0.065). The percentage
of apoptotic GFP-positive cells was also determined by flow cytometry (B) (*, P  0.002). In an independent experiment, GFP CD4 effector T
cells were transferred into M. avium-infected C57BL/6 (closed columns) or B6.IFN-/ (gray columns) mice and the frequency of apoptotic cells
was determined 4 days later (C) (*, P 	 0.07; **, P 	 0.02). Two independent experiments were performed. Data represent means 
 standard
deviations, with n 	 4 (experiment 1) or n 	 3 (experiment 2).
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investigate the mechanism further, we continued to test addi-
tional candidate molecules directly involved in T-cell demise.
Analysis of mice with the mutated forms of selected TNFR
superfamily members. Given that several of the TNFR super-
family molecules are involved in the induction of apoptosis of
T cells, we investigated whether specific members of this family
were involved in the T-cell depletion seen here. Mice deficient
in CD95/Fas (TNFRSF-6), the lpr mice, or mice with engi-
neered mutations in either the type 1 (p55) or the type 2 (p75)
receptors for TNF (TNFRSF 1A and 1B) were therefore in-
fected and the cellular response examined. T-cell loss in both
the lpr and p75/ mice was observed to occur even at levels
superior to those of wild-type mice (Fig. 5A). Thus, T-cell
numbers at day 30 of infection were smaller in those mutant
mice than in C57BL/6 animals (P  0.01 in p75/ mice; P 
0.05 in lpr mice). In contrast to the B6 profile, the p55/ mice
exhibited a marked CD4 T-cell expansion (Fig. 5A) during
the first month. However, these mice succumbed to infection
by day 40 of infection, as previously reported by Ehlers et al.
(6), and further analysis of the cellular response could not be
performed. These mice appeared to be mounting a type 1
response, as indicated by high serum levels of IFN- (42-fold
higher in p55/ mice than in C57BL/6 mice; P  0.001) and
a high antigen-specific IFN- response by splenocytes (12-fold
higher than C57BL/6, P 0.001) (Fig. 5A). The p75/ and lpr
mice had IFN- serum levels and antigen-specific responses
similar to those of C57BL/6 mice (Fig. 5A). The susceptibility
of lpr and p75/ mice to infection was similar to that of
wild-type mice throughout the 3 months of infection studied
(Fig. 5A). No conclusive analysis could be made from the
p55/ mice as they succumbed early in infection, although a
trend for a reduction in mycobacterial loads was apparent on
day 30 of infection.
The fact that the p55-deficient mice exhibited a pronounced
type 1 cellular response implicated TNF as a potential regula-
tor of T-cell function. To investigate the role of TNF in T-cell
loss, we infected mice deficient in this cytokine. As was seen in
the p55/ mice, the TNF/ mice had a reduction in survival
during infection (mean survival time, 57.5 
 8.4 days; n 	 19
mice). These animals were studied until day 50 of infection,
FIG. 5. TNFR superfamily death receptors are not required for infection-induced T-cell death. (A) Growth of M. avium ATCC 25291 in the
spleen; number of splenic T cells in C57BL/6 (closed squares), B6.MRL.lpr (open squares), B6.TNFRSF1a/p55/ (circles), and B6.TNFRSF1b/
p75/ (triangles) mice; and IFN- concentrations in the serum and culture supernatants of B6 (closed columns), B6.MRL.lpr (open columns),
B6.TNFRSF1a/p55/ (dark gray columns), and B6.TNFRSF1b/p75/ (light gray columns) mice. Statistically significant differences between
mutant and B6 mice are labeled * (P  0.05) or ** (P  0.01). (B) T-lymphocyte depletion in TNF-deficient mice: C57BL/6 and B6.TNF/ mice
were intravenously infected with 106 CFU of M. avium 25291, and spleen cell populations and bacterial loads were evaluated at the indicated time
points; IFN- concentrations were evaluated in the serum and culture supernatants for B6 (closed columns) and B6.TNF/ (open columns) mice.
Statistically significant differences between mutant and B6 mice are labeled * (P  0.05). (C) T-lymphocyte depletion in chimeric Rag/ mice:
Rag/ mice that received T-cell-enriched spleen cells from either C57BL/6 or B6.TNFRp55/ mice 3 weeks earlier were intravenously infected
with 106 CFU of M. avium 25291, and spleen cell populations were evaluated at the indicated time points. Statistically significant differences
between infected and noninfected mice are labeled * (P  0.05) or ** (P  0.01). Data represent the means of five mice per group in one
experiment.
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showing no T-cell expansion at day 30 and exhibiting the same
type of T-cell loss at the last time point studied as that ob-
served in wild-type controls infected in parallel (Fig. 5B).
These mice were able to generate higher levels of IFN- in
serum, although the antigen-specific response was only mar-
ginally improved over the control mice (Fig. 5B). While these
data implicated TNF in the modulation of serum IFN-, TNF
does not seem to be mediating the T-cell depletion seen in this
model. To further investigate if p55 may mediate T-cell deple-
tion, we chimerized T-cell-deficient Rag/ mice with T cells
from either C57BL/6 or B6.p55/ mice and determined the
extent of T-cell depletion upon M. avium infection. These chi-
meras survived up to day 90 of infection and, as can be seen in
Fig. 5C, lymphocytes lacking the p55 molecule were as suscep-
tible to depletion as were intact lymphocytes. Thus, neither
TNF nor p55 is required for T-cell loss during M. avium infec-
tion.
Bcl-2 overexpression does not prevent T-cell loss during
M. avium infection. Our data implicate an apoptotic process in
the observed T-cell depletion, and we thus decided to investi-
gate the ability of antiapoptotic molecules in preventing this
depletion. Apoptosis that is initiated by caspase 9 following
leakage of cytochrome c from the mitochondria can be inhib-
ited by BCL2, a mitochondrial protein (16). Mice engineered
to overexpress human bcl-2 in hematopoietic cells have lym-
phocytes which are protected from certain forms of apoptosis
(16). These mice provided us with a tool to determine wheth-
er T-cell depletion was progressing through the cytochrome
c/caspase 9 pathway. We therefore infected these mice and
analyzed the T-cell response. Although the transgenic animals
had higher numbers of T cells at the beginning of infection,
they underwent the same level of T-cell depletion seen in the
control mice (Fig. 6A). Thus, at 90 days of infection, CD4 T
cells were reduced 66.6% in transgenic animals compared to
78.2% in C57BL/6 mice and CD8 T cells were reduced 84.8%
in transgenic animals compared to 84.5% in C57BL/6 mice.
Although bcl-2 transgenic mice had IFN- serum levels similar
to those of C57BL/6 mice (Fig. 6A), spleen cells from bcl-2
transgenic mice showed an increased ability to secrete IFN-
upon antigenic stimulation compared to the control cells (five-
fold at day 30 of infection; P 0.001) (Fig. 6A). Absolute num-
bers of IFN--producing T cells, as evaluated by the ELISpot
assay, remained proportionally higher in infected bcl-2 trans-
genic mice compared to C57BL/6 controls (data not shown).
This increase in IFN- did not alter the progression of bacte-
rial growth (Fig. 6A). It would thus appear that the apoptosis
seen in this model does not use the cytochrome c/caspase 9
(mitochondrial) pathway.
Reactive oxygen species are not responsible for the T-cell
loss. An alternative process whereby apoptosis can occur is via
products from the respiratory burst. The production of these
oxygen-free radicals is also enhanced in IFN--activated phago-
cytes. To determine whether products of the respiratory burst
were mediating the T-cell depletion in this model, we infected
mice deficient in the p47 chain of the NADPH oxidase
(p47phox/ mice) and monitored the cellular response. As
shown in Fig. 6B, p47phox/ mice showed similar T-cell loss
during infection while serum IFN- was within the range of
concentrations found in the control animals (Fig. 6B). Anti-
gen-specific responses in vitro were however higher in the
deficient mouse (3.9-fold at day 30 and 2.6-fold at day 60; P 
0.05), but this had no impact on bacterial growth (Fig. 6B).
DISCUSSION
We have used a highly virulent strain of M. avium to address
the role of different immune mediators in the loss of T cells
occurring during infection. The growth of this strain is not
FIG. 6. Growth of M. avium ATCC 25291 in the spleen, number of splenic T cells, and IFN- concentrations in serum and culture supernatants
in mice with different immunological deficiencies. (A) C57BL/6 (closed squares and columns) and C57BL/6.tgBcl2 (open squares and columns)
mice; (B) C57BL/6 (closed squares and columns) and B6.p47phox/ (open squares and columns) mice. Each group of graphs represents an
independent experiment using five mice per group and per time point. Results were confirmed in an independent experiment. Statistical differences
in IFN- production between the two mouse strains were labeled * (P  0.05) or ** (P  0.001).
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controlled in susceptible mice despite the emergence of an
immune response known to be protective against other less
virulent strains (9). Thus, since this strain resists the antimy-
cobacterial mechanisms induced during the immune response,
it is a suitable model to analyze the role in such T-cell deple-
tion of immune mediators like IFN- which play a protective
role against other mycobacteria without any interference on
the course of the infection. We found that T cells underwent
apoptosis at accelerated rates after the initial month of infec-
tion. This was similar to the results previously reported by the
group of Cheers and colleagues (14), although given the higher
virulence of the mycobacterial strain, the phenomenon oc-
curred with more rapid kinetics in our model. Our data extend
the observations by this group by revealing the role of IFN- in
the antigen-nonspecific elimination of these T cells and exclud-
ing classic mechanisms of T-cell apoptosis such as those me-
diated by TNF, NO, or Fas/CD95.
IFN- has been shown to lead to enhanced T-cell apoptosis
in mycobacterial infections and to down-regulate the immune
response to mycobacteria (3, 5, 27). Our data further highlight
the role of IFN- in limiting the immune response to myco-
bacteria, namely, by promoting T-cell apoptosis and depletion.
However, given the virulence of the M. avium strain used, the
consequences were dramatically severe with a depletion of T
cells up to 99% of the normal number as determined in the
spleen. In this study, we showed that T-cell loss does not occur
in IFN--deficient animals when infected with M. avium and
that these animals show increased rates of lymphocyte prolif-
eration. The IFN- leading to T-cell depletion was produced
by the T cells themselves but also had a T-cell-independent
origin since chimeric mice with normal innate immunity and a
T-cell compartment deficient in its ability to secrete IFN- still
showed marked CD8 T-cell depletion. The depletion of
CD4 T cells in these chimeras did not however reach statis-
tical significance, raising the possibility that different subsets of
T cells may differ in their threshold for IFN--induced demise.
The nature of the non-T-cell population secreting IFN- was
not analyzed here, but we have previously shown that signifi-
cant amounts of IFN- can be produced by cells expressing NK
cell markers, in particular, Thy1 and DX5, during M. avium
infection (8). Thus, it is likely that NK cells regulate the ex-
pansion of T cells as well as their elimination through the
secretion of IFN-. Although IFN- was required for the loss
of T cells, the increased production of this cytokine in some of
the mutant strains did not apparently accelerate the rate of
disappearance of the T cells.
In contrast to the report by Dalton et al. (5), we did not find
nitric oxide required for T-cell depletion. The reason for this
discrepancy most likely lies in the fact that we analyzed the role
of this reactive species in vivo whereas the former work used an
in vitro system to determine its role in T-cell apoptosis. Addi-
tionally, there might be differences associated with the myco-
bacterial species used, since the study by Dalton et al. focused
on BCG. IFN- may directly induce T-cell death by promoting
the synthesis of caspase 8 in the T cells (28), but in our system,
IFN- most likely acts indirectly by activating other cell types,
namely macrophages, which by themselves trigger T-cell death.
This was established using chimeric mice that possessed T cells
lacking the receptor for IFN-. However, the pathway trig-
gered and the receptors involved remain to be identified. TNF
signaling was not required for the induction of T-cell loss,
although signaling through the type 1 TNF receptor may be
involved in the restriction of CD4 T-cell expansion early in
infection (Fig. 5). Since mice deficient in the type 1 TNF
receptor (6) or TNF itself (data shown here and our unpub-
lished observations) die prematurely from infection by M.
avium, addressing the role of TNF and its type 1 receptor in
these animals is not feasible since T-cell loss normally occurs
after day 30 of infection in B6 animals. Therefore, we used
chimerized Rag-deficient mice harboring T cells defective in
the expression of type 1 TNF receptors and showed that TNF
signaling was not required for the extensive loss of T cells.
Mice deficient in the type 2 TNF receptor survived the infec-
tion long enough to allow similar analysis and to show that
signaling through that receptor is also not required for the
observed T-cell loss. We also showed that oxygen radicals
produced through the respiratory burst in phagocytes, a path-
way activated by the action of IFN- in these cells, are not
required for the demise of T cells.
The fact that overexpression of functionally active human
Bcl-2 did not prevent the loss of T cells would argue that T-cell
death occurs through a mitochondrial-independent pathway,
namely, through the triggering of surface-associated death re-
ceptors. Yet, we were able to exclude the involvement of either
CD95/Fas and the type 1 TNF receptor, two molecules con-
taining death domains and known to trigger apoptosis in T
cells. There remain other possible candidates that should be
investigated for their participation in this process of T-cell
elimination, such as the receptors for TNF-related apoptosis-
inducing ligand. These data contrast with recent results re-
ported by Zhong et al. (38), who showed that apoptosis of
CD4 T cells during infection by M. avium was dependent on
CD95/Fas and that of CD8 T cells was prevented by overex-
pression of Bcl-2. The course of infection studied by the latter
group is however distinct from the one we studied. Whereas
infection by strain 25291 leads to T-cell depletion as early as
the second month of infection, the apoptosis studied by Zhong
and colleagues was evaluated at 16 weeks of infection. Differ-
ences in the kinetics of the infection may therefore result in the
triggering of different pathways of T-cell elimination. Although
we have studied only Bcl-2 for reasons related to availability of
an animal model, it should be stressed that apoptosis pathways
involving the mitochondria are regulated by additional mem-
bers of the BCL family.
The mechanism leading to T-cell depletion in our system
was antigen nonspecific in nature, since activated transgenic
TCR-expressing T cells with an irrelevant specificity were elim-
inated at increased rates in infected animals compared to un-
infected controls. Furthermore, this elimination was reduced
when the transfer was done into IFN--deficient mice com-
pared to control C57BL/6 animals. The requirement for prior
T-cell activation was not assessed, but given the extensive de-
pletion occurring during infection, it is likely that both acti-
vated and naı¨ve cells may undergo apoptosis. Alternatively,
bystander activation could lead to T-cell activation just pre-
ceding their death. Our data provide evidence of extensive
peripheral depletion of the T cells, namely, by showing in-
creased apoptosis of endogenous T cells or of adoptively trans-
ferred effector T cells. However, additional mechanisms could
influence and worsen the loss of T cells such as decreased
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thymic output of new cells related either to thymic deficiencies
or to decreased myelopoiesis. We have observed marked inva-
sion of the bone marrow by infected macrophages, and mice do
develop anemia at late stages of the infection (unpublished
data). Also, we have observed thymic atrophy in mice infected
by this M. avium strain (9). The relative contribution of these
factors is presently being assessed in our laboratories.
In the present experiments, we found that resistance to the
infection with M. avium was not affected by relatively large
variations in the secretion of IFN- such as those observed
among bcl-2 transgenic mice. This is consistent with prior ob-
servations in other models where we found that increasing
IFN- secretion by treatment with recombinant IL-12 or block-
ing of the IL-10 receptor did not increase protection against
infection (31–33). Also, low T-cell numbers appear not to be
the reason of the susceptibility to this highly virulent strain of
M. avium, since bcl-2 transgenic animals had increased T-cell
numbers throughout the course of the infection, namely, those
that produce IFN- and yet were as permissive to M. avium
25291 growth as the control mice.
The only instance where control of mycobacterial prolifera-
tion was achieved was with NOS2/ mice. Not only was
M. avium 25291 found to be resistant to NO as previously
described by us (15), but NO was required for the mycobacte-
ria to proliferate in the host. The basis for this phenomenon is
yet unknown, but NO might affect the emergence of some
unidentified protective mechanism, although the increase in
T-cell numbers or IFN- responses by themselves cannot ac-
count for the observed resistance of NOS2/ mice. A role in
granuloma development has also been described by Ehlers et
al. (7) who, however, did not find any difference in bacterial
loads following treatment with a chemical inhibitor of NO
synthase. Residual amounts of NO produced after chemical
inhibition may justify this difference between the two models.
Another alternative explanation is that M. avium may utilize
NO in its metabolism in the macrophage after the emergence
of the immune response, namely when hypoxic conditions set
in inside the granulomas. We are currently pursuing studies in
order to clarify the latter possibility.
Although we focused our study on T cells, the ones involved
in protective immunity, extensive B-cell death also occurred
during infection by the virulent M. avium strain used. Whether
such B-cell depletion involves similar mechanisms remains to
be determined.
The final mechanism of IFN--mediated T-cell depletion
remains to be uncovered. New information has shown that this
cytokine may increase the expression of caspases in different
cell types (4, 11, 20, 28, 35). This would make them more prone
to undergo apoptosis by one of many different apoptotic stim-
uli. However, we saw that T cells unable to directly respond to
IFN- are still susceptible to infection-induced death. These
data have important implications not only in the context of
mycobacterial infections but also to understand other infec-
tions where T-cell demise occurs at increased rates as a con-
sequence of intense immune activation. In human tuberculosis,
an association between increased apoptosis and IFN- secre-
tion in the lesions has been described (20), suggesting that the
phenomenon described here as a generalized one may also
occur in a more discrete and localized infection. Showing that
a cytokine which is pivotal in the expression of protective
immunity may in addition promote susceptibility by leading to
the elimination of T cells is a finding of great biological signif-
icance since the balance between the levels of IFN- needed
for the control of the pathogen and those sufficient for the
demise of T cells may determine the fate of the infection.
Finally, there are also implications in the design of vaccines
which are frequently screened based on their ability to induce
strong IFN- responses. In this regard, we have shown that
IFN- may interfere with the development of protective im-
mune responses to tuberculosis during vaccination with myco-
bacterial proteins (21).
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